Leavell Investment Management, Inc. Eli Lilly & CO Transaction History

Leavell Investment Management, Inc.

$1.98 Billion
Q3 2024

A detailed history of Leavell Investment Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Leavell Investment Management, Inc. holds 6,130 shares of LLY stock, worth $4.74 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

6,130

Previous 6,006 2.06%

Holding current value

$4.74 Million

Previous $5.44 Million 0.13%

% of portfolio

0.27%

Previous 0.3%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$772.14 - $960.02 $95,745 - $119,042	124 Added 2.06%	6,130 $5.43 Million
Q2 2024 Jul 17, 2024	BUY	$724.87 - $909.04 $210,937 - $264,530	291 Added 5.09%	6,006 $5.44 Million
Q1 2024 Apr 24, 2024	SELL	$592.2 - $792.28 $6,514 - $8,715	-11 Reduced 0.19%	5,715 $4.45 Million
Q4 2023 Jan 23, 2024	BUY	$525.19 - $619.13 $92,433 - $108,966	176 Added 3.17%	5,726 $3.34 Million
Q3 2023 Oct 16, 2023	BUY	$434.7 - $599.3 $348,629 - $480,638	802 Added 16.89%	5,550 $2.98 Million
Q2 2023 Jul 19, 2023	SELL	$350.74 - $468.98 $36,476 - $48,773	-104 Reduced 2.14%	4,748 $2.23 Million
Q1 2023 Apr 13, 2023	BUY	$310.63 - $364.82 $1,553 - $1,824	5 Added 0.1%	4,852 $1.67 Million
Q4 2022 Jan 17, 2023	BUY	$321.55 - $374.67 $37,621 - $43,836	117 Added 2.47%	4,847 $1.77 Million
Q3 2022 Oct 17, 2022	BUY	$296.48 - $337.87 $38,245 - $43,585	129 Added 2.8%	4,730 $1.53 Million
Q2 2022 Jul 28, 2022	SELL	$278.73 - $327.27 $161,384 - $189,489	-579 Reduced 11.18%	4,601 $1.49 Million
Q3 2021 Oct 26, 2021	SELL	$221.6 - $272.71 $53,405 - $65,723	-241 Reduced 4.45%	5,180 $1.2 Million
Q1 2021 Apr 15, 2021	SELL	$164.32 - $212.72 $1,643 - $2,127	-10 Reduced 0.18%	5,421 $1.01 Million
Q4 2020 Jan 26, 2021	BUY	$130.46 - $172.63 $32,615 - $43,157	250 Added 4.83%	5,431 $917,000
Q2 2020 Jul 23, 2020	BUY	$136.42 - $164.18 $13,778 - $16,582	101 Added 1.99%	5,181 $851,000
Q1 2020 Apr 16, 2020	BUY	$119.05 - $147.35 $16,667 - $20,629	140 Added 2.83%	5,080 $705,000
Q4 2019 Jan 22, 2020	SELL	$106.92 - $132.43 $21,384 - $26,486	-200 Reduced 3.89%	4,940 $649,000
Q3 2019 Oct 28, 2019	BUY	$106.79 - $116.16 $50,938 - $55,408	477 Added 10.23%	5,140 $575,000
Q2 2019 Jul 18, 2019	SELL	$110.79 - $129.32 $22,158 - $25,864	-200 Reduced 4.11%	4,663 $517,000
Q1 2019 Apr 16, 2019	SELL	$111.31 - $131.02 $1,780 - $2,096	-16 Reduced 0.33%	4,863 $631,000
Q4 2018 Jan 24, 2019	SELL	$105.9 - $118.64 $3,282 - $3,677	-31 Reduced 0.63%	4,879 $565,000
Q1 2018 Apr 25, 2018	BUY	$74.21 - $87.6 $18,552 - $21,900	250 Added 5.36%	4,910 $380,000
Q3 2017 Oct 25, 2017	BUY	$77.07 - $85.54 $359,146 - $398,616	4,660	4,660 $399,000

Others Institutions Holding LLY

# of Institutions

4,012

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $735B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Leavell Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Leavell Investment Management, Inc. with notifications on news.

Account

Leavell Investment Management, Inc. Eli Lilly & CO Transaction History